Follow
Alexey Stukalov
Alexey Stukalov
Seer, Inc.
Verified email at seer.bio
Title
Cited by
Cited by
Year
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network Tissue source sites: Duke University ...
Nature 455 (7216), 1061-1068, 2008
73192008
Gene essentiality and synthetic lethality in haploid human cells
VA Blomen, P Májek, LT Jae, JW Bigenzahn, J Nieuwenhuis, J Staring, ...
Science 350 (6264), 1092-1096, 2015
8602015
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
A Stukalov, V Girault, V Grass, O Karayel, V Bergant, C Urban, DA Haas, ...
Nature 594 (7862), 246-252, 2021
5832021
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
KVM Huber, E Salah, B Radic, M Gridling, JM Elkins, A Stukalov, ...
Nature 508 (7495), 222-227, 2014
4372014
Artemisinins target GABAA receptor signaling and impair α cell identity
J Li, T Casteels, T Frogne, C Ingvorsen, C Honore, M Courtney, ...
Cell 168 (1), 86-100. e15, 2017
3822017
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
F Grebien, M Vedadi, M Getlik, R Giambruno, A Grover, R Avellino, ...
Nature chemical biology 11 (8), 571-578, 2015
2792015
Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS
M Varjosalo, R Sacco, A Stukalov, A Van Drogen, M Planyavsky, S Hauri, ...
Nature methods 10 (4), 307-314, 2013
2292013
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
A Fauster, M Rebsamen, KVM Huber, JW Bigenzahn, A Stukalov, ...
Cell death & disease 6 (5), e1767-e1767, 2015
1932015
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
S Sadegh, J Matschinske, DB Blumenthal, G Galindez, T Kacprowski, ...
Nature communications 11 (1), 3518, 2020
1652020
Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action
MV Babak, SM Meier, KVM Huber, J Reynisson, AA Legin, MA Jakupec, ...
Chemical science 6 (4), 2449-2456, 2015
1522015
An orthogonal proteomic survey uncovers novel Zika virus host factors
P Scaturro, A Stukalov, DA Haas, M Cortese, K Draganova, A Płaszczyca, ...
Nature 561 (7722), 253-257, 2018
1502018
A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape
P Hubel, C Urban, V Bergant, WM Schneider, B Knauer, A Stukalov, ...
Nature immunology 20 (4), 493-502, 2019
1482019
Functional dissection of the TBK1 molecular network
A Goncalves, T Bürckstümmer, E Dixit, R Scheicher, MW Gorna, E Karayel, ...
PloS one 6 (9), e23971, 2011
1342011
Imprinted Igf2r silencing depends on continuous Airn lncRNA expression and is not restricted to a developmental window
F Santoro, D Mayer, RM Klement, KE Warczok, A Stukalov, DP Barlow, ...
Development 140 (6), 1184-1195, 2013
1012013
Clinical significance of genetic aberrations in secondary acute myeloid leukemia
JD Milosevic, A Puda, L Malcovati, T Berg, M Hofbauer, A Stukalov, ...
American journal of hematology 87 (11), 1010-1016, 2012
1002012
Germline RBBP6 mutations in familial myeloproliferative neoplasms
AS Harutyunyan, R Giambruno, C Krendl, A Stukalov, T Klampfl, T Berg, ...
Blood, The Journal of the American Society of Hematology 127 (3), 362-365, 2016
622016
The RNA‐binding protein HuR/ELAVL1 regulates IFN‐β mRNA abundance and the type I IFN response
B Herdy, T Karonitsch, GI Vladimer, CSH Tan, A Stukalov, C Trefzer, ...
European journal of immunology 45 (5), 1500-1511, 2015
572015
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms
J Li, K Bennett, A Stukalov, B Fang, G Zhang, T Yoshida, I Okamoto, ...
Molecular systems biology 9 (1), 705, 2013
532013
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
A Skucha, J Ebner, J Schmöllerl, M Roth, T Eder, A César-Razquin, ...
Nature Communications 9 (1), 1983, 2018
512018
Blackboxoptim. jl
R Feldt, A Stukalov
See https://github. com/robertfeldt/BlackBoxOptim. jl, 2018
482018
The system can't perform the operation now. Try again later.
Articles 1–20